Journal of Gastrointestinal Surgery

, Volume 13, Issue 1, pp 74–84 | Cite as

Multiagent Chemotherapy for Isolated Colorectal Liver Metastases: A Single-centered Retrospective Study

  • Srinevas K. Reddy
  • Gloria Broadwater
  • Donna Niedzwiecki
  • Andrew S. Barbas
  • Herbert I. Hurwitz
  • Johanna C. Bendell
  • Michael A. Morse
  • Bryan M. Clary
original article



Few studies identifying variables associated with prognosis after resection of colorectal liver metastases (CLM) account for treatment with multiagent chemotherapy (fluoropyrmidines with irinotecan, oxaliplatin, bevacizumab, and/or cetuximab). The objective of this retrospective study was to determine the effect of multiagent chemotherapy on long-term survival after resection of CLM.


Demographics, clinicopathologic tumor characteristics, treatments, and long-term outcomes were reviewed.


From 1996 to 2006, 230 patients underwent resection of CLM. Treatment strategies before and after resection included fluoropyrimidine monotherapy (n = 34 and n = 39), multiagent chemotherapy (n = 81 and n = 73), and observation (n = 115 and n = 118). Prehepatectomy treatment strategy was not associated with overall survival. Actuarial 4-year survival was 63%, 39%, and 40% for patients treated with multiagent chemotherapy, fluoropyrimidine monotherapy, and observation after hepatectomy, p = 0.06. Posthepatectomy multiagent chemotherapy (p = 0.04, HR 0.52 [0.27–1.03]), duration of posthepatectomy chemotherapy treatment of 2 months or longer (p = 0.05, HR 0.49 [0.25–0.99]), carcino-embryonic antigen level >10 ng/mL (p = 0.03, HR 2.09, 95% CI [1.32–3.32]), and node positive primary tumor (p = 0.002, HR 1.79 [1.06–3.02]) were associated with overall survival in multivariate analysis.


The association of posthepatectomy multiagent chemotherapy with overall survival in this retrospective study indicates the need for prospective randomized trials comparing multiagent chemotherapy and fluoropyrimidine monotherapy for CLM.


Colorectal liver metastases Chemotherapy Hepatic resection 


  1. 1.
    Niu R, Yan TD, Zhu JC, et al. Recurrence and survival after hepatic resection with or without cryotherapy for liver metastases from colorectal carcinoma. Ann Surg Oncol. 2007;14:2078–2087.PubMedCrossRefGoogle Scholar
  2. 2.
    Minagawa M, Yamamoto J, Kosuge T, et al. Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: development and validation. Arch Surg. 2007;142:269–276. doi:10.1001/archsurg.142.3.269.PubMedCrossRefGoogle Scholar
  3. 3.
    Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg. 2000;231:487–499. doi:10.1097/00000658-200004000-00006.PubMedCrossRefGoogle Scholar
  4. 4.
    Kato T, Yasui K, Hirai T, et al. Therapeutic results for hepatic metastases of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum. 2003;46:S22–S31.PubMedGoogle Scholar
  5. 5.
    Jonas S, Thelen A, Benckert C, et al. Extended resections of liver metastases from colorectal cancer. World J Surg. 2007;31:511–521. doi:10.1007/s00268-006-0140-3.PubMedCrossRefGoogle Scholar
  6. 6.
    Figueras J, Torras J, Valls C, et al. Surgical resection of colorectal liver metastases in patients with expanded indications: a single-center experience with 501 patients. Dis Colon Rectum. 2007;50:478–488. doi:10.1007/s10350-006-0817-6.PubMedCrossRefGoogle Scholar
  7. 7.
    Tsai MS, Su YH, Ho MC, et al. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol. 2007;14:786–794. doi:10.1245/s10434-006-9215-5.PubMedCrossRefGoogle Scholar
  8. 8.
    Wei AC, Greig PD, Grant D, et al. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol. 2006;13:668–676. doi:10.1245/ASO.2006.05.039.PubMedCrossRefGoogle Scholar
  9. 9.
    Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection of colorectal metastases. Ann Surg. 2005;241:715–724. doi:10.1097/01.sla.0000160703.75808.7d.PubMedCrossRefGoogle Scholar
  10. 10.
    Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–321. doi:10.1097/00000658-199909000-00004.PubMedCrossRefGoogle Scholar
  11. 11.
    Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235:759–766. doi:10.1097/00000658-200206000-00002.PubMedCrossRefGoogle Scholar
  12. 12.
    Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients. Cancer. 1996;77:1254–1262. doi:10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I.PubMedCrossRefGoogle Scholar
  13. 13.
    Malik HZ, Hamady ZZR, Adair R, et al. Prognositic influence of multiple hepatic metastases from colorectal cancer. Eur J Surg Oncol. 2007;33:468–473. doi:10.1016/j.ejso.2006.09.030.PubMedCrossRefGoogle Scholar
  14. 14.
    Ercolani G, Grazi GL, Ravaioli M, et al. Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival. Arch Surg. 2002;137:1187–1192. doi:10.1001/archsurg.137.10.1187.PubMedCrossRefGoogle Scholar
  15. 15.
    Schindl M, Wigmore SJ, Currie EJ, et al. Prognostic scoring in colorectal cancer liver metastasis: development and validation. Arch Surg. 2005;140:183–189. doi:10.1001/archsurg.140.2.183.PubMedCrossRefGoogle Scholar
  16. 16.
    Altendorf-Hofmann A, Scheele J. A critical review of the major indicators of prognosis after resection of hepatic metastases form colorectal carcinoma. Surg Oncol Clin N Am. 2003;12:165–192. doi:10.1016/S1055-3207(02)00091-1.PubMedCrossRefGoogle Scholar
  17. 17.
    Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg. 1995;19:59–71. doi:10.1007/BF00316981.PubMedCrossRefGoogle Scholar
  18. 18.
    Mala T, Bohler G, Mathisen O, et al. Hepatic resection for colorectal metastases: can preoperative scoring predict outcome? World J Surg. 2002;26:1348–1353. doi:10.1007/s00268-002-6231-x.PubMedCrossRefGoogle Scholar
  19. 19.
    van Ooijen B, Wiggers T, Meijer S, et al. Hepatic resections for colorectal metastases in The Netherlands: a multi-institutional 10-year study. Cancer. 1992;70:28–34. doi:10.1002/1097-0142(19920701)70:1<28::AID-CNCR2820700105>3.0.CO;2-9.PubMedCrossRefGoogle Scholar
  20. 20.
    Bakalakos EA, Kim JA, Young DC, et al. Determinants of survival following hepatic resection for metastatic colorectal cancer. World J Surg. 1998;22:399–405. doi:10.1007/s002689900404.PubMedCrossRefGoogle Scholar
  21. 21.
    Ohlsson B, Stenram U, Tranberg KG. Resection of colorectal liver metastases: 25-year experience. World J Surg. 1998;22:268–277. doi:10.1007/s002689900381.PubMedCrossRefGoogle Scholar
  22. 22.
    Ambiru S, Miyazaki M, Isono T, et al. Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum. 1999;42:632–639. doi:10.1007/BF02234142.PubMedCrossRefGoogle Scholar
  23. 23.
    Laurent C, Cunha AS, Couderc P, et al. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg. 2003;90:1131–1136. doi:10.1002/bjs.4202.PubMedCrossRefGoogle Scholar
  24. 24.
    Iwatsuki S, Dvorchik I, Madariaga JR, et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 1999;189:291–299. doi:10.1016/S1072-7515(99)00089-7.PubMedCrossRefGoogle Scholar
  25. 25.
    Cady B, Jenkins RL, Steele GD, et al. Surgical margin in hepatic resection for colorectal metastases: a critical and improvable determinant of outcome. Ann Surg. 1998;227:566–571. doi:10.1097/00000658-199804000-00019.PubMedCrossRefGoogle Scholar
  26. 26.
    Jamison RL, Donohue JH, Nagorney DM, et al. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg. 1997;132:505–511.PubMedGoogle Scholar
  27. 27.
    Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg. 1992;216:495–503. doi:10.1097/00000658-199210000-00012.CrossRefGoogle Scholar
  28. 28.
    Hughes K, Scheele J, Sugarbaker PH. Surgery for colorectal cancer metastatic to the liver: optimizing the results of treatment. Surg Clin North Am. 1989;69:339–359.PubMedGoogle Scholar
  29. 29.
    Hughes KS, Rosenstein RB, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of long-term survivors. Dis Colon Rectum. 1988;31:1–4. doi:10.1007/BF02552560.PubMedCrossRefGoogle Scholar
  30. 30.
    Harmon KE, Ryan JA, Biehl TR, et al. Benefits and safety of hepatic resection for colorectal metastases. Am J Surg. 1999;177:402–404. doi:10.1016/S0002-9610(99)00070-7.PubMedCrossRefGoogle Scholar
  31. 31.
    Bradley AL, Chapman WC, Wright JK, et al. Surgical experience with hepatic colorectal metastasis. Am Surg. 1999;65:560–566.PubMedGoogle Scholar
  32. 32.
    Jenkins LT, Millikan KW, Bines SD, et al. Hepatic resection for metastatic colorectal cancer. Am Surg. 1997;63:605–610.PubMedGoogle Scholar
  33. 33.
    Doci R, Gennari L, Bignami P, et al. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg. 1991;78:797–801. doi:10.1002/bjs.1800780711.PubMedCrossRefGoogle Scholar
  34. 34.
    Nagashima I, Takada T, Matsuda K, et al. A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. J Hepatobiliary Pancreat Surg. 2004;11:79–83. doi:10.1007/s00534-003-0851-x.PubMedCrossRefGoogle Scholar
  35. 35.
    Nicoli N, Casaril A, Mangiante G, et al. Surgical treatment for liver metastases from colorectal carcinoma: results of 228 patients. Hepatogastroenterology. 2004;51:1810–1814.PubMedGoogle Scholar
  36. 36.
    Hohenberger P, Schlag PM, Gerneth T, et al. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases: predictive value and implications for adjuvant treatment based on multivariate analysis. Ann Surg. 1994;219:135–143. doi:10.1097/00000658-199402000-00005.PubMedCrossRefGoogle Scholar
  37. 37.
    Seifert JK, Bottger TC, Weigel TF, et al. Prognostic factors following liver resection for hepatic metastases from colorectal cancer. Hepatogastroenterology. 2000;47:239–246.PubMedGoogle Scholar
  38. 38.
    Harms J, Obst T, Thorban S, et al. The role of surgery in the treatment of liver metastases for colorectal cancer patients. Hepatogastroenterology. 1999;46:2321–2328.PubMedGoogle Scholar
  39. 39.
    Tanaka K, Shimada H, Ueda M, et al. Long-term characteristics of 5-year survivors after liver resection for colorectal metastases. Ann Surg Oncol. 2007;14:1336–1346. doi:10.1245/s10434-006-9071-3.PubMedCrossRefGoogle Scholar
  40. 40.
    Kokudo N, Seki M, Ohta H, et al. Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases. Ann Surg Oncol. 1998;5:706–712. doi:10.1007/BF02303481.PubMedCrossRefGoogle Scholar
  41. 41.
    Parks R, Gonen M, Kemeny N, et al. Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. J Am Coll Surg. 2007;204:753–763. doi:10.1016/j.jamcollsurg.2006.12.036.PubMedCrossRefGoogle Scholar
  42. 42.
    Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med. 2005;352:476–487. doi:10.1056/NEJMra040958.PubMedCrossRefGoogle Scholar
  43. 43.
    de Gramont A, Boni C, Navarro M, et al. Oxaliplatin/5FU/LV in adjuvant colon cancer: updated efficacy results of the MOSAIC trial including survival, with a median follow-up of six years. J Clin Oncol. 2007;25:165s. (ASCO Annual Meeting Proceedings Part 1. 25:Abstr 2007, 2007).Google Scholar
  44. 44.
    Kuebler JP, Wieand HS, O’Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NASBP C-07. J Clin Oncol. 2007;25:2198–2204. doi:10.1200/JCO.2006.08.2974.PubMedCrossRefGoogle Scholar
  45. 45.
    Bartlett DL, Berlin J, Lauwers GY, et al. Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol. 2006;13:1284–1292. doi:10.1245/s10434-006-9018-8.PubMedCrossRefGoogle Scholar
  46. 46.
    Portier G, Elias D, Bouche O, et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol. 2006;24:4976–4982. doi:10.1200/JCO.2006.06.8353.PubMedCrossRefGoogle Scholar
  47. 47.
    Nordlinger B, Sorbye H, Coulette L, et al. Final results of the EORTC intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. J Clin Oncol 2007;25:2s. (ASCO Annual Meeting Proceedings Part I. 25:Abstr LBA5, 2007).Google Scholar
  48. 48.
    Strasberg SM. Terminology of liver anatomy and liver resections: coming to grips with hepatic Babel. J Am Coll Surg. 1997;184:413–434.PubMedGoogle Scholar
  49. 49.
    Engstrom PF, Benson AB. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Colon Cancer. Version 1. (2007). Accessed 15 May 2007.
  50. 50.
    Charnsangavej C, Clary B, Fong Y, et al. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol. 2006;13:1261–1268. doi:10.1245/s10434-006-9023-y.PubMedCrossRefGoogle Scholar
  51. 51.
    Alberts SR. Evolving role of chemotherapy in resected liver metastases. J Clin Oncol. 2006;24:4952–4953. doi:10.1200/JCO.2006.07.9236.PubMedCrossRefGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2008

Authors and Affiliations

  • Srinevas K. Reddy
    • 1
  • Gloria Broadwater
    • 2
  • Donna Niedzwiecki
    • 3
  • Andrew S. Barbas
    • 1
  • Herbert I. Hurwitz
    • 4
  • Johanna C. Bendell
    • 4
  • Michael A. Morse
    • 4
  • Bryan M. Clary
    • 1
  1. 1.Department of SurgeryDuke University Medical CenterDurhamUSA
  2. 2.Department of Cancer Center BiostatisticsDuke University Medical CenterDurhamUSA
  3. 3.Department of Biostatistics and BioinformaticsDuke University Medical CenterDurhamUSA
  4. 4.Department of MedicineDuke University Medical CenterDurhamUSA

Personalised recommendations